Find Aprepitant manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

MARKET PLACE

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as:
Molecular Formula
C23H21F7N4O3
Molecular Weight
534.4  g/mol
InChI Key
ATALOFNDEOCMKK-OITMNORJSA-N

Aprepitant
1 2D Structure

Aprepitant

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one
2.1.2 InChI
InChI=1S/C23H21F7N4O3/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)37-20-19(13-2-4-17(24)5-3-13)34(6-7-36-20)11-18-31-21(35)33-32-18/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H2,31,32,33,35)/t12-,19+,20-/m1/s1
2.1.3 InChI Key
ATALOFNDEOCMKK-OITMNORJSA-N
2.1.4 Canonical SMILES
CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
2.1.5 Isomeric SMILES
C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H](N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
2.2 Create Date
2006-07-28
3 Chemical and Physical Properties
Molecular Weight 534.4 g/mol
Molecular Formula C23H21F7N4O3
XLogP34.2
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count11
Rotatable Bond Count6
Exact Mass534.15018768 g/mol
Monoisotopic Mass534.15018768 g/mol
Topological Polar Surface Area75.2 A^2
Heavy Atom Count37
Formal Charge0
Complexity810
Isotope Atom Count0
Defined Atom Stereocenter Count3
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 4  
Drug NameAprepitant
PubMed HealthAprepitant (By mouth)
Drug ClassesAntiemetic
Drug LabelEMEND (aprepitant) is a substance P/neurokinin 1 (NK1) receptor antagonist, chemically described as 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one. Its empiric...
Active IngredientAprepitant
Dosage FormCapsule
RouteOral
Strength125mg; 80mg; 40mg
Market StatusPrescription
CompanySandoz

2 of 4  
Drug NameEmend
PubMed HealthAprepitant (By mouth)
Drug ClassesAntiemetic
Drug LabelEMEND (aprepitant) is a substance P/neurokinin 1 (NK1) receptor antagonist, chemically described as 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one. Its empiric...
Active IngredientAprepitant; Fosaprepitant dimeglumine
Dosage FormCapsule; Powder
RouteIntravenous; Oral
Strengtheq 150mg base/vial; 125mg; 80mg; 40mg
Market StatusPrescription
CompanyMerck; Merck And

3 of 4  
Drug NameAprepitant
PubMed HealthAprepitant (By mouth)
Drug ClassesAntiemetic
Drug LabelEMEND (aprepitant) is a substance P/neurokinin 1 (NK1) receptor antagonist, chemically described as 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one. Its empiric...
Active IngredientAprepitant
Dosage FormCapsule
RouteOral
Strength125mg; 80mg; 40mg
Market StatusPrescription
CompanySandoz

4 of 4  
Drug NameEmend
PubMed HealthAprepitant (By mouth)
Drug ClassesAntiemetic
Drug LabelEMEND (aprepitant) is a substance P/neurokinin 1 (NK1) receptor antagonist, chemically described as 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one. Its empiric...
Active IngredientAprepitant; Fosaprepitant dimeglumine
Dosage FormCapsule; Powder
RouteIntravenous; Oral
Strengtheq 150mg base/vial; 125mg; 80mg; 40mg
Market StatusPrescription
CompanyMerck; Merck And

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Direct Compression

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Granulation

read-more
read-more

Solubilizers

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Taste Masking

read-more
read-more

Lubricants & Glidants

read-more
read-more

Coating Systems & Additives

read-more
read-more

Parenteral

read-more
read-more

Co-Processed Excipients

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Emulsifying Agents

read-more
read-more

Empty Capsules

read-more
read-more

Topical

read-more
read-more

Controlled & Modified Release

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

API Stability Enhancers

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for / Aprepitant API manufacturers, exporters & distributors?

Aprepitant manufacturers, exporters & distributors 1

25

PharmaCompass offers a list of Aprepitant API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Aprepitant manufacturer or Aprepitant supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Aprepitant manufacturer or Aprepitant supplier.

API | Excipient name

Aprepitant

Aprecap Manufacturers

A Aprecap manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aprecap, including repackagers and relabelers. The FDA regulates Aprecap manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aprecap API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Aprecap manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Aprecap Suppliers

A Aprecap supplier is an individual or a company that provides Aprecap active pharmaceutical ingredient (API) or Aprecap finished formulations upon request. The Aprecap suppliers may include Aprecap API manufacturers, exporters, distributors and traders.

click here to find a list of Aprecap suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Aprecap USDMF

A Aprecap DMF (Drug Master File) is a document detailing the whole manufacturing process of Aprecap active pharmaceutical ingredient (API) in detail. Different forms of Aprecap DMFs exist exist since differing nations have different regulations, such as Aprecap USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Aprecap DMF submitted to regulatory agencies in the US is known as a USDMF. Aprecap USDMF includes data on Aprecap's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Aprecap USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Aprecap suppliers with USDMF on PharmaCompass.

Aprecap JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Aprecap Drug Master File in Japan (Aprecap JDMF) empowers Aprecap API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Aprecap JDMF during the approval evaluation for pharmaceutical products. At the time of Aprecap JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Aprecap suppliers with JDMF on PharmaCompass.

Aprecap KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Aprecap Drug Master File in Korea (Aprecap KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Aprecap. The MFDS reviews the Aprecap KDMF as part of the drug registration process and uses the information provided in the Aprecap KDMF to evaluate the safety and efficacy of the drug.

After submitting a Aprecap KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Aprecap API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Aprecap suppliers with KDMF on PharmaCompass.

Aprecap CEP

A Aprecap CEP of the European Pharmacopoeia monograph is often referred to as a Aprecap Certificate of Suitability (COS). The purpose of a Aprecap CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Aprecap EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Aprecap to their clients by showing that a Aprecap CEP has been issued for it. The manufacturer submits a Aprecap CEP (COS) as part of the market authorization procedure, and it takes on the role of a Aprecap CEP holder for the record. Additionally, the data presented in the Aprecap CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Aprecap DMF.

A Aprecap CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Aprecap CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Aprecap suppliers with CEP (COS) on PharmaCompass.

Aprecap WC

A Aprecap written confirmation (Aprecap WC) is an official document issued by a regulatory agency to a Aprecap manufacturer, verifying that the manufacturing facility of a Aprecap active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Aprecap APIs or Aprecap finished pharmaceutical products to another nation, regulatory agencies frequently require a Aprecap WC (written confirmation) as part of the regulatory process.

click here to find a list of Aprecap suppliers with Written Confirmation (WC) on PharmaCompass.

Aprecap NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Aprecap as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Aprecap API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Aprecap as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Aprecap and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Aprecap NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Aprecap suppliers with NDC on PharmaCompass.

Aprecap GMP

Aprecap Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Aprecap GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Aprecap GMP manufacturer or Aprecap GMP API supplier for your needs.

Aprecap CoA

A Aprecap CoA (Certificate of Analysis) is a formal document that attests to Aprecap's compliance with Aprecap specifications and serves as a tool for batch-level quality control.

Aprecap CoA mostly includes findings from lab analyses of a specific batch. For each Aprecap CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Aprecap may be tested according to a variety of international standards, such as European Pharmacopoeia (Aprecap EP), Aprecap JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Aprecap USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty